Focus

November 11, 2005

Michael Brenner POPULATION GENETICS: Genetic Road Map Drawn for Tracing Route to Common Diseases
The Human Genome Project revealed the 99.9 percent of DNA shared among all people. But scientists believe that the crucial clues to health and disease are found in the slight genetic differences that make family history one of the strongest risk factors for all diseases. Genes and other DNA are inherited in mostly unchanging blocks, called haplotypes, that are flanked by hotspots of genetic recombination. In the Oct. 27 Nature, David Altshuler and colleagues including (left to right) Stephen Schaffner, Pardis Sabeti, and Paul de Bakker report the first rough guide to haplotype variations in a resource called the HapMap. Researchers believe the map will speed discovery of genetic differences that predispose people to particular diseases.

Dan Frenkel, Howard Weiner, and Ruth Maron NEUROSCIENCE: Drug May Cause Weight Loss Through Brain Cell Growth
A surprising new study suggests that an experimental drug leads to long-term weight loss by spurring growth of new brain cells. The research, led by Jeffrey Flier, found that mice treated with the drug sprouted these cells in a region of the brain that controls energy balance. The results, published in the Oct. 28 Science, draw a provocative connection between brain plasticity and the regulation of a seemingly hard-wired function of the brain.

Kenneth WilliamsDERMATOLOGY: Skin Cells Engineered to Mimic Thymus in Producing Mature T Cells
Immune T cells are born and educated in the specialized surroundings of the thymus, a complex environment that researchers have long sought to replicate in the lab. Now, by adapting easily obtained skin cells as a stand-in for the thymus, Thomas Kupper and Rachael Clark have designed a three-dimensional living factory that generates mature, functional human T cells from bone marrow stem cells. Their technique, described in the Nov. 1 Journal of Clinical Investigation, offers for the first time a practical method for creating human T cells that could one day be used therapeutically to boost a patient’s immune system after bone marrow transplantation or to fight cancer or HIV.

 

 

 

 

Copyright 2005 by the President and Fellows of Harvard College